OREANDA-NEWS. April 15, 2015. Vectura Group plc (LSE: VEC; "Vectura" or "the Company"), announces its intention to close its site in Gem?nden, Germany, effective by March 2016.

The Gem?nden site was acquired by Vectura as part of the acquisition of Activaero GmbH in March 2014 and is currently involved in the production of the Company's nebuliser devices, supporting clinical trials and marketing of the devices.  In order to improve manufacturing efficiencies, all activities currently carried out in Gem?nden will be transferred to Vectura's facilities in Gauting, Germany, Chippenham UK and Cambridge UK, and to a contract manufacturing organisation for any commercial production.  As a result, the Company will close the site by March 2016.

Dr Chris Blackwell, Chief Executive of Vectura, commented: "The decision to close our Gem?nden site was a strategic and necessary one.  It will rationalise our business operations and deliver more cost-effective production of our nebulisers.  We retain the capabilities and capacity at our three remaining sites to support all our business operations.  I would like to thank all the employees at Gem?nden for their hard work and assure them of our continuing support as we prepare for the closure of the site in early 2016."